Wahome S - Search Results

Year	Number of Results
2019	2
2020	1
2021	3
2022	2
2023	3
2024	1
2025	3

1

High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.

Penner J, Ombajo LA, Nkuranga J, Otieno E, Nyakoe D, Wanjohi R, Mbewa V, Ndinya F, Eshiwani S, Wahome S, Bhagani S, Pozniak A, Gregson CL. Penner J, et al. Among authors: wahome s. HIV Med. 2025 Mar;26(3):382-389. doi: 10.1111/hiv.13741. Epub 2024 Nov 21. HIV Med. 2025. PMID: 39569696 Clinical Trial.

2

Second-Line Switch to Dolutegravir for Treatment of HIV Infection.

Ombajo LA, Penner J, Nkuranga J, Mecha J, Mburu M, Odhiambo C, Ndinya F, Aksam R, Njenga R, Wahome S, Muiruri P, Eshiwani S, Kimani M, Ngugi C, Pozniak A. Ombajo LA, et al. Among authors: wahome s. N Engl J Med. 2023 Jun 22;388(25):2349-2359. doi: 10.1056/NEJMoa2210005. N Engl J Med. 2023. PMID: 37342923 Clinical Trial.

3

High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya.

Penner J, Ombajo LA, Otieno D, Nkuranga J, Mburu M, Wahome S, Pozniak A, Bhagani S. Penner J, et al. Among authors: wahome s. PLoS One. 2023 Jun 23;18(6):e0285787. doi: 10.1371/journal.pone.0285787. eCollection 2023. PLoS One. 2023. PMID: 37352206 Free PMC article.

4

Environmental contamination across multiple hospital departments with multidrug-resistant bacteria pose an elevated risk of healthcare-associated infections in Kenyan hospitals.

Odoyo E, Matano D, Tiria F, Georges M, Kyanya C, Wahome S, Mutai W, Musila L. Odoyo E, et al. Among authors: wahome s. Antimicrob Resist Infect Control. 2023 Mar 29;12(1):22. doi: 10.1186/s13756-023-01227-x. Antimicrob Resist Infect Control. 2023. PMID: 36978195 Free PMC article.

5

Ten Thousand-Fold Higher than Acceptable Bacterial Loads Detected in Kenyan Hospital Environments: Targeted Approaches to Reduce Contamination Levels.

Odoyo E, Matano D, Georges M, Tiria F, Wahome S, Kyany'a C, Musila L. Odoyo E, et al. Among authors: wahome s. Int J Environ Res Public Health. 2021 Jun 25;18(13):6810. doi: 10.3390/ijerph18136810. Int J Environ Res Public Health. 2021. PMID: 34201911 Free PMC article.

6

The Role of Self-Efficacy in HIV treatment Adherence and its interaction with psychosocial factors among HIV Positive Adolescents in Transition to Adult Care in Kenya.

Gitahi-Kamau N, Wahome S, Memiah P, Bukusi EA. Gitahi-Kamau N, et al. Among authors: wahome s. Vulnerable Child Youth Stud. 2022;17(4):308-319. doi: 10.1080/17450128.2021.1954736. Epub 2021 Aug 23. Vulnerable Child Youth Stud. 2022. PMID: 36439942 Free PMC article.

7

Transcriptome-Guided Identification of Pectin Methyl-Esterase-Related Enzymes and Novel Molecular Processes Effectuating the Hard-to-Cook Defect in Common Bean (Phaseolus vulgaris L.).

Toili MEM, de Koning R, Kiekens R, Ndumba N, Wahome S, Anami S, Githiri SM, Angenon G. Toili MEM, et al. Among authors: wahome s. Foods. 2022 Jun 9;11(12):1692. doi: 10.3390/foods11121692. Foods. 2022. PMID: 35741889 Free PMC article.

8

Behavioral Interventions can Mitigate Adverse Pregnancy Outcomes Among Women Conceiving on ART and Those Initiated on ART During Pregnancy: Findings From the MOTIVATE Trial in Southwestern Kenya.

Onono M, Odwar T, Wahome S, Helova A, Bukusi EA, Hampanda K, Turan J, Abuogi L. Onono M, et al. Among authors: wahome s. J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):46-55. doi: 10.1097/QAI.0000000000002521. J Acquir Immune Defic Syndr. 2021. PMID: 33306563 Free PMC article.

9

Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.

Mugendi AG, Kubo MN, Nyamu DG, Mwaniki LM, Wahome SK, Haberer JE. Mugendi AG, et al. Among authors: wahome sk. Neurol Res Int. 2019 Oct 30;2019:5173289. doi: 10.1155/2019/5173289. eCollection 2019. Neurol Res Int. 2019. PMID: 31781391 Free PMC article.

10

Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial.

Ombajo LA, Penner J, Nkuranga J, Omodi V, Otieno E, Ndinya F, Wahome S, Pozniak A. Ombajo LA, et al. Among authors: wahome s. Clin Infect Dis. 2025 Apr 30;80(4):889-892. doi: 10.1093/cid/ciae514. Clin Infect Dis. 2025. PMID: 39589132 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year